Zylox-Tonbridge Medical Technology Co (HKSE:02190) Interest Coverage: 0 (At Loss) (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02190 Zylox-Tonbridge Medical Technology Co Ltd HKSE:02190
81 GF Score
Price HK$19.95
GF Value HK$35.80
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zylox-Tonbridge Medical Technology Co Interest Coverage?

Zylox-Tonbridge Medical Technology Co HKSE:02190 +3.05% 81 Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus rates HKSE:02190 with a GF Score™ of 81/100 and a GF Value™ of HK$35.80 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Zylox-Tonbridge Medical Technology Co ranks better than 82.83% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Zylox-Tonbridge Medical Technology Co's Operating Income for the six months ended in Dec. 2025 was HK$137 Mil. Zylox-Tonbridge Medical Technology Co's Interest Expense for the six months ended in Dec. 2025 was HK$0 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Zylox-Tonbridge Medical Technology Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Zylox-Tonbridge Medical Technology Co's Interest Coverage or its related term are showing as below:

HKSE:02190' s Interest Coverage Range Over the Past 10 Years
Min: 35.44   Med: 126.72   Max: 219.7
Current: 219.7

HKSE:02190's Interest Coverage is ranked better than
82.83% of 466 companies
in the Medical Devices & Instruments industry
Industry Median: 16.545 vs HKSE:02190: 219.70

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zylox-Tonbridge Medical Technology Co  (HKSE:02190) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Zylox-Tonbridge Medical Technology Co Interest Coverage Related Terms

Zylox-Tonbridge Medical Technology Co Interest Coverage Historical Data

* Premium members only.

The historical data trend for Zylox-Tonbridge Medical Technology Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Zylox-Tonbridge Medical Technology Co Interest Coverage Chart

Zylox-Tonbridge Medical Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
Get a 7-Day Free Trial 0.00 0.00 0.00 35.44 218.00

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 36.61 33.94 82.84 0.00

HKSE:02190 vs ABT, SYK, MDT: Interest Coverage Comparison

For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zylox-Tonbridge Medical Technology Co Interest Coverage vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's Interest Coverage falls into.


HKSE:02190
81GF Score
Zylox-Tonbridge Medical Technology Co Ltd HKSE:02190
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zylox-Tonbridge Medical Technology Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zylox-Tonbridge Medical Technology Co's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Zylox-Tonbridge Medical Technology Co's Interest Expense was HK$-1 Mil. Its Operating Income was HK$246 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$1 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2025 )/Interest Expense (A: Dec. 2025 )
=-1*246.345/-1.13
=218.00

Zylox-Tonbridge Medical Technology Co's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Here, for the six months ended in Dec. 2025, Zylox-Tonbridge Medical Technology Co's Interest Expense was HK$0 Mil. Its Operating Income was HK$137 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0 (At Loss) mean?
Zylox-Tonbridge Medical Technology Co (HKSE:02190) has a Interest Coverage of 0 (At Loss) as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Zylox-Tonbridge Medical Technology Co and its competitors. Over the past decade, Zylox-Tonbridge Medical Technology Co's Interest Coverage has ranged from 35.44 to 219.70. According to the industry distribution chart, Zylox-Tonbridge Medical Technology Co ranks #80 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 17.2%.
Is Zylox-Tonbridge Medical Technology Co's Interest Coverage too high?
Zylox-Tonbridge Medical Technology Co's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 35.44 to a high of 219.70. Based on the distribution chart, Zylox-Tonbridge Medical Technology Co ranks #80 out of 466 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Zylox-Tonbridge Medical Technology Co has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zylox-Tonbridge Medical Technology Co's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zylox-Tonbridge Medical Technology Co ranks #80 out of 466 companies for Interest Coverage. This places Zylox-Tonbridge Medical Technology Co in the top 17% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 16.55. Historically, Zylox-Tonbridge Medical Technology Co's own Interest Coverage has ranged from 35.44 to 219.70 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.55, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Zylox-Tonbridge Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zylox-Tonbridge Medical Technology Co's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zylox-Tonbridge Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co (HKSE:02190) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$35.80, compared to a current price of HK$19.95 — trading 44.3% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Zylox-Tonbridge Medical Technology Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Zylox-Tonbridge Medical Technology Co (HKSE:02190), the current Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zylox-Tonbridge Medical Technology Co (HKSE:02190) Overvalued in 2026?

Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co stock appears to be undervalued. The current stock price of HK$19.95 is trading 44.3% below its estimated GF Value™ of HK$35.80. GuruFocus considers Zylox-Tonbridge Medical Technology Co to be Significantly Undervalued.

Key valuation signals for HKSE:02190:

  • Interest Coverage: 0 (At Loss)
  • GF Value™: HK$35.80 vs. price of HK$19.95 (44.3% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zylox-Tonbridge Medical Technology Co Business Description

Other Exchanges 818:Germany
Address 270 Shuyun Road, Cangqian Street, Zylox-Tonbridge Industrial Park, Yuhang District, Zhejiang Province, Hangzhou, CHN
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's products include Thrombite Clot Retriever Device (Thrombite CRD), Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB), and others. The company derives majority of its revenue from PRC.
81GF Score

Get the complete analysis for HKSE:02190

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$19.95
Price
HK$35.80
GF Value